Americas
AstraZeneca’s billion-dollar vaccine acquisition follows med-tech advancements
AstraZeneca has embarked on a transformative journey with the acquisition of Icosavax, a Seattle-based biotech company, in a landmark deal valued at up to US$1.1 billion....
12/12/2023